Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression throughFxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells. Issue 2 (25th November 2015)

• Record Type: Journal Article
• Authors: Selmin, Ornella I; Fang, Changming; Lyon, Adam M; Doetschman, Tom C; Thompson, Patricia A; Martinez, Jesse D; Smith, Jeffrey W; Lance, Peter M; Romagnolo, Donato F
• Is Part Of: Journal of nutrition. Volume 146:Issue 2(2016)
• Page Start: 236
• Page End: 242
• Publication Date: 2015-11-25
• Subjects: farnesoid X receptor -- bile acid metabolism -- adenomatous polyposis coli -- deoxycholic acid -- epigenetics -- CpG methylation -- inflammation -- colon cancer; Nutrition -- Periodicals; Diet -- Periodicals; 613.205
• DOI: 10.3945/jn.115.216580
• Languages: English
• ISSNs: 0022-3166

Abstract

Abstract: Background: The farnesoid X receptor (FXR) regulates bile acid (BA) metabolism and possesses tumor suppressor functions. FXR expression is reduced in colorectal tumors of subjects carrying inactivated adenomatous polyposis coli ( APC ). Identifying the mechanisms responsible for this reduction may offer new molecular targets for colon cancer prevention. Objective: We investigated how APC inactivation influences the regulation of FXR expression in colonic mucosal cells. We hypothesized that APC inactivation would epigenetically repress nuclear receptor subfamily 1, group H, member 4 ( FXR gene name) expression through increased CpG methylation. Methods: Normal proximal colonic mucosa and normal-appearing adjacent colonic mucosa and colon tumors were collected from wild-type C57BL/6J and Apc -deficient ( Apc Min /+ ) male mice, respectively. The expression of Fxr, ileal bile acid-binding protein ( Ibabp ), small heterodimer partner ( Shp ), and cyclooxygenase-2 ( Cox-2 ) were determined by real-time polymerase chain reaction. In both normal and adjacent colonic mucosa and colon tumors, we measured CpG methylation of Fxr in bisulfonated genomic DNA. In vitro, we measured the impact of APC inactivation and deoxycholic acid (DCA) treatment on FXR expression in human colon cancer HCT-116 cells transfected with silencing RNA for APC and HT-29 cells carrying inactivated APC . Results: In Apc Min /+ mice, constitutive CpG methylation of the Fxrα3/4 promoter was linked to reduced (60–90%) baseline Fxr, Ibabp, and Shp and increased Cox-2 expression in apparently normal adjacent mucosa and colon tumors. Apc knockdown in HCT-116 cells increased cellular myelocytomatosis (c-MYC) and lowered (∼50%) FXR expression, which was further reduced (∼80%) by DCA. In human HCT-116 but not HT-29 colon cancer cells, DCA induced FXR expression and lowered CpG methylation of FXR . Conclusions: We conclude that the loss of APC function favors the silencing of FXR expression through CpG hypermethylation in mouse colonic mucosa and human colon cells, leading to reduced expression of downstream targets (SHP, IBABP) involved in BA homeostasis while increasing the expression of factors (COX-2, c-MYC) that contribute to inflammation and colon cancer.